Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITI-007 PET study in stable schizophrenia
NCT02288845Phase 2Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Oct 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lumateperone in schizophrenia, sponsored by Intra-Cellular Therapies. Started Oct 2014; status: completed.
02
Drugs
lumateperone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02288845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02288845.